Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.

Bronchiolitis may predispose children to respiratory illnesses

22 Mar 2019

Bronchiolitis in infancy carries a three- to fivefold increased risk of developing respiratory illnesses, including asthma, wheeze, and lower and upper respiratory tract infections (LRTI and URTI) in the first 5 years of life, a study has found.

Researchers looked at a cohort of 613,377 children, among whom 16,288 (2.7 percent) had been admitted at least once for bronchiolitis in the first year of life. Relative to those who had no history of the lung infection, infants admitted with bronchiolitis were more likely to be boys, reside in deprived areas, be preterm at birth and be born with a comorbid condition.

A total of 68,315 admissions for respiratory illness were recorded between 1 and 5 years of age, with 49,509 children (8.07 percent) having at least one respiratory admission. These admissions occurred more frequently among children with vs without bronchiolitis during infancy (21.7 percent vs 7.6 percent).

On multivariable Cox regression analysis, bronchiolitis during infancy was associated with an elevated risk of developing respiratory diseases within 5 years of life (adjusted hazard ratio [aHR], 2.82; 95 percent CI, 2.72–2.92). The highest risk was seen for asthma (aHR, 4.35; 4.00–4.73) and wheezing (aHR, 5.02; 4.64–5.44). Significant risk increases were also observed for LRTI (aHR, 3.10; 2.91–3.31) and URTI (aHR, 2.34; 2.23–2.45).

The findings underscore the importance of communicating to parents the increased risk of subsequent childhood respiratory illness in infants with bronchiolitis, researchers said. Clinicians should also stress the weight of reducing other respiratory health risk factors, such as passive smoke exposure, in this at-risk population.

With regard to future studies, researchers recommended linking laboratory virological data with large population level admission data, as well as controlling for environmental smoke exposure due to its significance as a risk factor.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019
Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.
11 Sep 2019
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Pearl Toh, Yesterday
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.